Tuesday, July 18, 2017 11:13:11 AM
There were 3M (approx) shares outstanding, Now after the financing of the preferred depending at price the conversions happen at there could be more (maybe much more) than 25M or more of common shares, so for $5M they bought say 25M out of 28M shares or about 90% of the overall company. That will leave the current shareholders with 10% or less of IMUC. This share price should drop much further if I am right and the probable conversion price will be the minimum of 35 cents not the current 65 cents. Now this is a toxic financing. They basically gave the company away to the new buyers. I wonder who the new buyers are - they are walking away with it all should some years down the road the tech prove out for a limited group.
Recent IMUC News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/02/2023 07:11:57 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM